Chr. Hansen and Nestlà have settled a legal dispute involving alleged infringements on Human Milk Oligosaccharide (HMO) patents arising from October 2020âs acquisition of Jennewein Biotechnologie.
Read more about it via https://www.nutraingredients.com/Article/2021/05/17/Chr.-Hansen-and-Nestle-settle-HMO-patent-litigation?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS
No comments:
Post a Comment